Literature DB >> 26271281

Maternal depression from pregnancy to 4 years postpartum and emotional/behavioural difficulties in children: results from a prospective pregnancy cohort study.

Hannah Woolhouse1, Deirdre Gartland2, Fiona Mensah3,4, Rebecca Giallo2, Stephanie Brown2,5.   

Abstract

Considerable attention has been focused on women's mental health in the perinatal period and the subsequent impacts on children. Comparatively, we know much less about maternal depression at later time points and the potential implications for child mental health. The objective of this paper was to explore the association between maternal depression and child emotional/behavioural difficulties at 4 years postpartum, taking into account earlier episodes of perinatal depression. The Maternal Health Study is a prospective cohort study of 1,507 nulliparous women. Maternal depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS) in early pregnancy and at 3, 6 and 12 months postpartum and again at 4 years postpartum. Maternal depressive symptoms at 4 years postpartum were associated with significantly increased odds of child emotional/behavioural difficulties (odds ratio (OR) = 3.46, 95 % confidence interval (CI) = 2.21-5.43). This remained significant after adjusting for earlier episodes of perinatal depression and socio-demographic characteristics (OR = 2.07, 95 % CI = 1.18-3.63). We also observed a robust association between child difficulties at age 4 and measures of socio-economic disadvantage. Our findings suggest a pressing need to rethink current paradigms of maternal health surveillance and extend mental health surveillance and support to at least 4 years postpartum.

Entities:  

Keywords:  Child behaviour; Child mental health; Maternal depression; Screening

Mesh:

Year:  2015        PMID: 26271281     DOI: 10.1007/s00737-015-0562-8

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  12 in total

1.  A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk.

Authors:  Etienne Weisskopf; Monia Guidi; Céline J Fischer; Myriam Bickle Graz; Etienne Beaufils; Kim An Nguyen; Mathilde Morisod Harari; Sylvie Rouiller; Sophie Rothenburger; Pascal Gaucherand; Behrouz Kassai-Koupai; Cristina Borradori Tolsa; Manuella Epiney; Jean-François Tolsa; Yvan Vial; Jean-Michel Hascoët; Olivier Claris; Chin B Eap; Alice Panchaud; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2020-04-14       Impact factor: 4.335

2.  Use of the Antenatal Risk Questionnaire to Assess Psychosocial Risk Factors Associated with Risk for Postpartum Depression: A Pilot Study.

Authors:  Sharon L Ruyak; Fares Qeadan
Journal:  J Midwifery Womens Health       Date:  2018-08-23       Impact factor: 2.388

3.  Psychiatry and Obstetrics: An Imperative for Collaboration.

Authors:  M Camille Hoffman; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2017-03-01       Impact factor: 18.112

4.  Prenatal and postnatal maternal distress and offspring temperament: A longitudinal study.

Authors:  Angelina R Sutin; Jason E Strickhouser; Amanda A Sesker; Antonio Terracciano
Journal:  J Psychiatr Res       Date:  2022-01-17       Impact factor: 4.791

5.  Role of Maternal Depression on Child Development: A Prospective Analysis from Pregnancy to Early Childhood.

Authors:  Guido G Urizar; Ricardo F Muñoz
Journal:  Child Psychiatry Hum Dev       Date:  2021-03-01

6.  Maternal Depressive Symptoms and Child Behavior among Mexican Women and Their Children.

Authors:  Emily P Flynn; Esther O Chung; Emily J Ozer; Lia C H Fernald
Journal:  Int J Environ Res Public Health       Date:  2017-12-18       Impact factor: 3.390

7.  Maternal perinatal and concurrent depressive symptoms and child behavior problems: a sibling comparison study.

Authors:  Line C Gjerde; Espen Moen Eilertsen; Ted Reichborn-Kjennerud; Tom A McAdams; Henrik Daae Zachrisson; Imac Maria Zambrana; Espen Røysamb; Kenneth S Kendler; Eivind Ystrom
Journal:  J Child Psychol Psychiatry       Date:  2017-02-23       Impact factor: 8.982

Review 8.  Allopregnanolone in postpartum depression: Role in pathophysiology and treatment.

Authors:  Samantha Meltzer-Brody; Stephen J Kanes
Journal:  Neurobiol Stress       Date:  2020-02-03

9.  "To Suffer in Paradise": Feelings Mothers Share on Portuguese Facebook Sites.

Authors:  Filipa César; Patrício Costa; Alexandra Oliveira; Anne Marie Fontaine
Journal:  Front Psychol       Date:  2018-10-01

10.  Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression.

Authors:  Miranda C Cooper; Hannah S Kilvert; Paul Hodgkins; Neil S Roskell; Adi Eldar-Lissai
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.